TCL Archive In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It November 1, 1974
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
